Stocks-NEU.ASX-Neuren Pharmaceuticals Ltd

Neuren Pharmaceuticals Ltd NEU.ASX

‎A$‎12.05-0.22(-1.79%)(1D)

• Delayed prices by CBOE AUS • in AUD

Invest in Neuren Pharmaceuticals Ltd
Today

Create an eToro account to buy NEU.ASX stock on a secure, user-friendly, multi-asset trading platform.

Neuren Pharmaceuticals Ltd NEU.ASX

Buy NEU.ASX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

EIFF.PA

Societe de la Tour Eiffel SA

Eastman Kodak Company

Alerion Clean Power S.p.A

‎€‎21.75

+6.36%

SBAC

SBA Communications Corporation

MAX

*Past performance is not an indication of future results

Jump to:

About NEU.ASX >
How to Buy? >
Top Guides >

The Neuren Pharmaceuticals Ltd share price is stable this week.

The Neuren Pharmaceuticals Ltd share price today is ‎A$‎12.05, reflecting a ‎-1.79‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of NEU.ASX is ‎A$‎1.51B with an average volume in the last three months of 529108.33. The stock has a P/E ratio of 50.04 and a dividend yield of 0%. With the stock’s beta sitting at 0.05

NEU.ASX Key Metrics

Market Cap

‎A$‎1.51B

Day’s Range

‎A$‎11.83 - ‎A$‎12.31

52W Range

‎A$‎8.58 - ‎A$‎22.94

Average Volume (3M)

529108.33

Price-Earnings Ratio

50.04

Revenue

‎A$‎64.63M

Dividend (Yield)

‎A$‎0 (0%)

Prev Close

‎A$‎12.05

EPS

‎A$‎0.24

Beta

0.05

How can I buy Neuren Pharmaceuticals Ltd stocks?

To purchase Neuren Pharmaceuticals Ltd:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Neuren Pharmaceuticals Ltd (NEU.ASX) page and place an order to buy Neuren Pharmaceuticals Ltd.

Buy NEU.ASX

Looking for more information? Check out our guide on Academy.

What Is Neuren Pharmaceuticals Ltd?

Neuren Pharmaceuticals Limited is a biopharmaceutical company with operations spanning the globe. Specialising in the development of new therapies for neurological disorders, its robust offering is making substantial strides in the healthcare sector.

Operating under the larger umbrella of the pharmaceutical industry, Neuren Pharmaceuticals Limited is involved in critical biotechnological research and development processes. The company's standout products include Trofinetide, an innovative drug used in the treatment of Rett syndrome and Fragile X syndrome, affirming Neuren's important position in the pharmaceutical landscape.

Monitor the NEU.ASX share price by adding it to your eToro watchlist.

CEO

Jon Pilcher

Employees

Founded

2004

Melbourne, Victoria (VIC), AU

Med Tech

Sydney

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Neuren Pharmaceuticals Ltd
Today

Create an eToro account to buy NEU.ASX stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Neuren Pharmaceuticals Ltd stock?

The current price of NEU.ASX is ‎A$‎12.05.

What are analysts’ forecasts for Neuren Pharmaceuticals Ltd?

Analysts offer forecasts for Neuren Pharmaceuticals Ltd based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Neuren Pharmaceuticals Ltd?

The market capitalisation of Neuren Pharmaceuticals Ltd is ‎A$‎1.51B

Daily Movers

Explore the biggest stocks movers on the market.